Recalls for Nexus Pharmaceuticals Inc.

Benztropine Mesylate Injection (Nexus Pharmaceuticals): Recall - Visible Particulate Matter
08/02/2013 Medical Recall

Risk of thromboembolism, some life-threatening (such as pulmonary emboli), as well as other serious adverse events.

  • Company:
    Nexus Pharmaceuticals Inc.
Nexus Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Benztropine Mesylate Injection, USP 2 mg/2 mL (1 mg/mL), in 2 mL Single Dose Vials
08/02/2013 Food Recall

Nexus Pharmaceuticals Inc. is voluntarily recalling two lots of Benztropine Mesylate Injection, USP, 2 mg/2mL (1mg/mL) in 2 mL single dose vials due to the potential presence of visible particulate matter in the vials. This recall is being conducted at the user level.

  • Company:
    Nexus Pharmaceuticals Inc.
  • Problem
    Violation Of Federal Flammability Standards